Last reviewed · How we verify

NCT03902379

Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer

Withdrawn NA Last updated 19 April 2021
What this trial tests

NA trial testing Internet-Based Intervention in Endometrial Carcinoma. Withdrawn.

Timeline
27 July 2016
Primary endpoint
31 May 2020
31 May 2020

Quick facts

Lead sponsorRutgers, The State University of New Jersey
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Start date27 July 2016
Primary completion31 May 2020
Estimated completion31 May 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Rutgers, The State University of New Jersey

Who can join

18 and older, female only, with Endometrial Carcinoma or Stage 0 Fallopian Tube Cancer AJCC v7. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot clinical trial studies how well web-based coping and communication skills intervention works in improving psychological adaptation in patients with gynecological cancer. Web-based intervention, such as coping and communication skills intervention, may help doctors to get a better understanding of ways to help gynecological cancer patients cope with their cancer experience.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Internet-Based Intervention

Trials testing the same drug.

Other recruiting trials for Endometrial Carcinoma

Currently open trials in the same condition.

Other Rutgers, The State University of New Jersey trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03902379.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing